Plasma Fractionation Market Size, Share, and Forecast by 2028
Plasma Fractionation Market: Strategic Insights
Plasma Fractionation Market
-
CAGR (2021 - 2028)6.3% -
Market Size 2021
US$ 26.58 Billion -
Market Size 2028
US$ 40.73 Billion
Market Dynamics
GROWTH DRIVERS
- Rising need for plasma-based treatments
- Growing awareness of blood disorders
FUTURE TRENDS
- Advances in protein fractionation
- Increase in the number of plasma-derived therapies
OPPORTUNITIES
- Expansion in the global healthcare market
- Growth in blood plasma-based therapies
Key Players
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Immunoglobulin
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other Plasma Products
Application - Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Other Applications
End User - Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Get Free Sample For